Aerospace firm Rocket Labs (RKLB) rocketed up 34% on Friday, notching its best day ever. The firm's massive burst in performance follows its report of strong earnings numbers, topping Q1 revenue estimates.
Rocket Lab Corporation (RKLB) Q1 2026 Earnings Call Transcript
Rocket Lab NASDAQ: RKLB reported what executives described as the strongest first quarter in the company's history, with record revenue, gross margin, backlog, cash and launch contract activity as it continued to expand across launch services, satellite systems and national security programs.
Rocket Lab's shares blasted to a record high after topping first-quarter revenue estimates and announcing its largest launch deal ever. Shares have quadrupled over the last year, benefiting from President Donald Trump's Golden Dome project and enthusiasm leading into SpaceX's IPO.
With a massive $2 billion backlog and the Neutron rocket on the horizon, RKLB is positioning itself as the premier public alternative to SpaceX.
Rocket Lab NASDAQ: RKLB has spent years building toward a moment like this. On May 7, the company reported its fiscal Q1 2026 results after the bell, and the numbers were exceptional across every meaningful metric.
The shares of Rocket Lab Corp (NASDAQ:RKLB) are 18.8% higher to trade at $93.31 at last glance, after the aerospace manufacturer announced a first-quarter revenue win, with earnings coming in line with estimates.
Rocket Lab reported better-than-expected first-quarter sales. That wasn't the half of it.
Rocket Lab Corporation (RKLB) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.12 per share a year ago.
Rocket Lab stock (NASDAQ: RKLB) has become one of the market's favorite regret trades. It went public at $11.58, fell to a record low of $3.79 in 2022, and now trades around $84.65, after a long run built on launch execution, defense contracts and a growing backlog.
RKLB heads into Q1 results with launch and space systems momentum, but Neutron and R&D spending, premium valuation and recurring losses may have weighed on the stock.
Rocket Lab remains a Buy, with over 25% medium-term upside potential despite high valuation and sector volatility. RKLB's Space Systems segment drives margin expansion, with Q4 2025 non-GAAP gross profit margin at 44.3% and backlog up 73% YoY to $1.85 billion. Recent acquisitions, including Mynaric and Geost, strengthen vertical integration and support execution on major government contracts.